Explosives trace detector approved for passenger and baggage screening at U.S. airports
Wilmington, MA-based Implant Sciences Corporation, a high technology supplier of systems and sensors for homeland security and defense markets, has announced that its QS-B220 desktop explosives trace detector has completed the certification process for the Transportation Security Administration's (TSA) Explosive Trace Detection (ETD) qualification requirements for aviation checkpoint and checked baggage screening. The QS-B220 becomes the first ETD with a non-radioactive source to be added to the TSA's Qualified Product List (QPL).
"The addition of the QS-B220 to TSA's QPL is the single most significant achievement in our Company's history," said Implant Sciences' President and CEO, Glenn D. Bolduc. "We're very proud to be able to deliver this innovative product for the protection of travelers in our country. Every member of the Implant Sciences team has done a phenomenal job of getting us to this point. We would also like to recognize the support we have received from our shareholders and other investors over the last few years while we have been pursuing this most significant qualification. Without their support this would not have been achievable."
The QS-B220 uses Ion Mobility Spectrometry to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
Implant Sciences is a developer and manufacturer of advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. Implant Sciences is only the third manufacturer, and the sole American-owned company, to currently have an ETD system named as a Qualified Product by the US Transportation Security Administration.